THE TRUSTEES OF COLUMBIA UNIVERSITY;YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM;MORRIA BIOPHARMACEUTICALS
发明人:
YEDGAR, SAUL,PRINCE, ALICE,YUVAL, COHEN
申请号：
EP06800600
公开号：
EP1922076A4
申请日:
2006.08.01
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
This invention provides for the use of compounds represented by the structure of the general formula (A): wherein L is a lipid or a phospholipid, Z is either nothing, ethanolamine, serine, inositol, choline, or glycerol, Y is either nothing or a spacer group ranging in length from 2 to 30 atoms, X is a physiologically acceptable monomer, dimer, oligomer, or polymer, wherein X is a glycosaminoglycan； and n is a number from 1 to 1000, wherein any bond between L, Z, Y and X is either an amide or an esteric bond in treating a subject suffering from cystic fibrosis, reducing or delaying the mortality of a subject suffering from cystic fibrosis or ameliorating symptoms associated with cystic fibrosis.
